Oramed to Host Webinar Highlighting Detailed Safety and Efficacy Data from Its Positive Phase 2 Clinical Trial of ORMD-0801 for NASH
- Webinar scheduled for Thursday, November 17, 2022, at 11:00 a.m. EST
- Featuring key opinion leader discussion on current treatment landscape
To register for the event, please click the following link: https://touchconference.zoom.us/webinar/register/WN_dy3jzksKQA6kBKZdT5a0_g
Professor Yaron Ilan, M.D., Director of the Department of Medicine at the Hebrew University-Hadassah Medical Center, and Joel Neutel, M.D., Director of Research, at the Orange County Research Center and Memorial Research Medical Clinic, will provide commentary on this data and the need for a NASH treatment that is safe and well-tolerated.
The formal presentation will be followed by a live question and answer session with Dr. Ilan and Dr. Neutel, who served as primary investigators of this study.
Professor Yaron Ilan, M.D
Dr. Yaron Ilan is the Director of the Department of Medicine at the Hebrew University-Hadassah Medical Center. Dr. Ilan served as the Vice Dean of the Hebrew University-Hadassah Medical School. Dr. Ilan was a Visiting Professor at Harvard University, working on novel immunotherapies. His main area of research is development of immunomodulatory drugs for fatty liver disease, diabetes, inflammatory bowel disease and liver cancer. Dr. Ilan holds over 50 patents for discoveries based on his innovative research and has authored more than 300 articles. He is the inventor of several drugs and medical devices developed by pharmaceutical companies, several that have reached the clinical market. Dr. Ilan is the founder of several companies and is a medical director and advisor for biotech companies.
Joel Neutel, M.D.
Dr. Neutel serves as Director of Research at the Orange County Research Center in Orange County, California and at the Memorial Research Medical Clinic in Long Beach, California, where he has served as Study Principal Investigator on several hundred multinational cardiovascular & metabolic trials. Dr. Neutel has had extensive experience serving the biopharmaceutical industry in the areas of clinical and academic research, as well as marketing strategic planning. After receiving his medical degree at the University of Witwatersrand in Johannesburg, South Africa, Dr. Neutel completed his internship and residency in internal medicine at the Veterans Administration Medical Center in Long Beach and The University of California, Irvine. Dr. Neutel has authored numerous abstracts, journal articles and book chapters. He has conducted extensive research in such disciplines as cardiovascular medicine, endocrinology, and central nervous system disorders, with special attention to the pharmacotherapy of the diseases in these areas.